AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04550234 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Verinurad prolonged release gelatin Capsule
Description: Randomized subjects will receive oral dose of Verinurad gelatin capsule.
Study NCT03949478 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Description: Ibuprofen to be prepared in a tablet that is not distinguishable from nifedipine or placebo tablet.
Study NCT03949478 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nifedipine
Description: Nifedipine to be prepared in a tablet that is not distinguishable from ibuprofen or placebo tablet.
Study NCT03949478 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sugar pill to be prepared in a tablet that is not distinguishable from ibuprofen or nifedipine tablet.
Study NCT04755907 — intervention group
Intervention type: PROCEDURE
Intervention: surgical resection
Description: Surgical resection will be performed for locoregional lesions or liver metastases.
Study NCT04755907 — intervention group
Intervention type: OTHER
Intervention: adjuvant chemotherapy
Description: Regimens of adjuvant chemotherapy are directed by clinical guidance and experience.
Study NCT04755907 — intervention group
Intervention type: OTHER
Intervention: neoadjuvant therapy
Description: Regimens of neoadjuvant chemotherapy are directed by clinical guidance and experience.
Study NCT03923556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Administration of Sugammadex intravenously at a dose appropriate for the reversal of neuromuscular blockade (usually 2-4 mg/kg) at the end of the surgery before tracheal extubation
Study NCT03923556 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neostigmine
Description: Administration of Neostigmine intravenously at a dose appropriate for the reversal of neuromuscular blockade (usually 0.03-0.07 mg/kg) at the end of the surgery before tracheal extubation
Study NCT04897347 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robotic Trunk-Support-Trainer (TruST)
Description: This will involve tailoring the level of postural assistance via force fields and systematically introduce postural task-progression across training sessions. Age-appropriate activities, including toys and games, will be used in training.~- Twelve 2hr training sessions (3 times per week for 4 weeks)
Study NCT04897347 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Static Trunk Support
Description: This will involve static support for the trunk via a trained therapist. Age-appropriate activities, including toys and games, will be used in training.~- Twelve 2hr training sessions (3 times per week for 4 weeks)
Study NCT05689177 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by The Finlay Vaccine Institute and The Centre of Molecular Immunology (Republic of Cuba)
Description: Booster dose administration
Study NCT04759001 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Donor FMT
Description: This intervention is represented by the administration, in the recipients' gut, of donor microbiota through FMT
Study NCT04759001 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo FMT
Description: This intervention is represented by the administration, in the recipients' gut, of a placebo through FMT
Study NCT05878951 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA
Description: Intra-detrusor OnabotulinumtoxinA is commonly known as botox
Study NCT05159245 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abemaciclib
Description: CDK4/6
Study NCT05159245 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tepotinib
Description: MET ex14
Study NCT05159245 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabrafenib
Description: RAF
Study NCT05159245 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trametinib
Description: MEK1, MEK2
Study NCT05159245 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabrafenib+Trametinib
Description: RAF, MEK1, MEK2
Study NCT05964933 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Complete Pulpotomy
Description: Complete caries removal and excision of the entire coronal pulp to the level of the root canal orifices will be performed. After haemostasis, the pulp chamber will be filled with Biodentine® and a final direct restoration placed in 1 or 2 visits.~If there is no bleeding from the exposed pulp, pulpectomy and root canal treatment will be performed instead, and the patient will be excluded from the study.
Study NCT05159245 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemigatinib
Description: FGFR2
Study NCT05964933 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pulpectomy and Root Canal Treatment
Description: After complete caries removal and pulp exposure, Pulpectomy will be performed to remove all pulp tissues. Conventional root canal treatment will be performed using rotary instrumentation followed by obturation with gutta percha and traditional sealers in 1 or 2 visits. A final restoration will be placed to ensure a good coronal seal, and this may include full coronal coverage restorations if clinically indicated.
Study NCT04846465 — intervention group
Intervention type: OTHER
Intervention: Screening in picture archiving and communication system (PACS) .
Description: Screening in picture archiving and communication system (PACS) , the images of the participants who underwent computed tomography (CT) of the femur and acetabulum.
Study NCT05532605 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: cardiac rehabilitation phase I protocols
Description: cardiac rehab phase I protocols: ankel pumps, limbs ROMs, bed mobility. Do 5-10 minutes daily of breath awareness practice on your own.
Study NCT05532605 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cardiac rehab phase I protocols + Mindfullness base therapy
Description: cardiac rehab phase I protocols: ankel pumps, limbs ROMs, bed mobility. Do 5-10 minutes daily of breath awareness practice on your own. Plus Mindfullness base therapy
Study NCT06021509 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NovoClasp® transcatheter mitral valve clip and steerable guide catheter
Description: The experimental device is a class III implanted valve device, which will be used to treat the mitral valve regurgitation via transcatheter edge-to-edge repair.
Study NCT06354478 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine Hydrochloride 0.5 MG/ML
Description: Will be used either alone or in combination of gabapentin
Study NCT06354478 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin
Description: Will be used either alone or in combination of Dexmedetomidine
Study NCT05293236 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ApTOLL
Description: ApTOLL is an aptamer (DNA single strain) designed to block TLR4 (toll-like receptor 4)
Study NCT05293236 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Saline for intravenous infusion
Study NCT04739878 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Airway Ultrasound
Description: Comparison between Airway ultrasound and CT cervical
Study NCT06137651 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples
Study NCT06137651 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan
Study NCT06137651 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT06137651 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Undergo radiation therapy
Study NCT06137651 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Resection
Description: Undergo surgery
Study NCT05722418 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CB-011
Description: CB-011 allogeneic CAR T cell therapy targeting BCMA Cyclophosphamide Chemotherapy for lymphodepletion Fludarabine Chemotherapy for lymphodepletion
Study NCT06137651 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trotabresib
Description: Given PO
Study NCT06137651 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vinorelbine
Description: Given IV
Study NCT05782738 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous Coronary Intervention
Description: Use dedicated two stents technique for treatment of coronary bifurcation stenosis
Study NCT04516980 — intervention group
Intervention type: OTHER
Intervention: Questionnaires administration
Description: Administration of Identification of Functional Ankle Instability (IdFAI) and the following assessment scales: Self-reported question assess the ankle instability as functional/stable or not functional/unstable, Foot and Ankle ability Measure Italian Version - Activity Daily Living (FAAM-I/ADL), Short-form 36-item Health Survey Italian Version (SF-36), Numeric Rate Scale pain (NRS Pain), Visual Analogic Scale Ankle Instability (VAS ankle instability).~After a week the participants will fill in the following questionnaires: Identification of Functional Ankle Instability (IdFAI), Numeric Rate Scale pain (NRS Pain), Visual Analogic Scale Ankle Instability (Vas ankle instability) with the additional question to measure the change in complaints.
Study NCT06200909 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation
Description: 8-week mindfulness meditation program, based on Kabat-Zinn's MBSR program and modified for caregivers. The intervention will be led by MBSR-trained facilitators.
Study NCT06200909 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducation
Description: A lecture-style program based on the 10 KeysTM to Healthy Aging Course, an evidence-based program for older adults. The program will be delivered by a facilitator experienced in delivering similar content.
Study NCT06200909 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Wait list control
Description: Participants will receive two hours of respite from their caregiving responsibilities per week, for eight weeks. They will be given the opportunity to participate in either the MM or the PSY condition following completion of testing.
Study NCT06432582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: hepatomiR
Description: hepatomiR is a CE-certified test intended for gauging liver-related outcomes. It quantifies the levels of hsa-miR-122-5p, hsa-miR-192-5p, and hsa-miR-151a-5p in human plasma samples. A proprietary algorithm is then used to compute a liver function score (hepatomiR p-score).
Study NCT06252545 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: semistructured interviews
Description: Black subjects with pancreatic cancer will provide insight on their experience discussing clinical trials and preferences for communicating clinical trial information
Study NCT06252545 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: feedback
Description: Black subjects with pancreatic cancer will provide feedback on mHealth app prototype.
Study NCT06029439 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NMRA-335140
Description: Participants will receive NMRA-335140 at a dose of 80 mg once daily (QD), orally during a 52-week treatment period.
Study NCT05677841 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stabilization exercise+lifestyle recommendation
Description: Exercise program was given both spinal stabilization exercises focusing on the pelvic floor 3 days a week for eight weeks and a booklet related to the lower urinary system symptoms, the structure of the pelvic floor and healthy behavioral strategies recommendations (fluid intake, diet, weight control etc. )
Study NCT05677841 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: lifestyle recommendations
Description: The control group will be given a booklet related to the lower urinary system symptoms, the structure of the pelvic floor and healthy behavioral strategies recommendations (fluid intake, diet, weight control etc. )
Study NCT06207864 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of tissue, blood, saliva, and stool samples
Study NCT06207864 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Return of Results
Description: Receive results
Study NCT06207864 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Surveys and Interviews
Study NCT05694689 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Placebo is normal saline, given in the first 28 days after birth, prepared to have the same volume and appearance as vitamin D, which is a clear odorless solution.
Study NCT05694689 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 800 IU/day vitamin D supplementation with feedings in the first 28 days after birth
Description: 800 IU/day Vitamin D supplementation until 400 IU/ day are provided as part of usual care. At that point the intervention becomes a supplement of 400 IU/day above that given with usual care. In this way all infants in the intervention group receive 800 IU/day of vitamin D total supplementation in the first 28 days after birth with feedings.
Study NCT02738073 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Control: Saline
Study NCT02738073 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic Acid
Study NCT05607927 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Parks surgery
Description: Parks surgery
Study NCT05607927 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PE-Bacon surgery
Description: PE-Bacon surgery
Study NCT05694689 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Co-interventions will be unaffected and provided based on the judgment of the attending neonatal faculty and NICU policies and routine practices
Study NCT05694689 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual Care
Description: Co-interventions will be unaffected and provided based on the judgment of the attending neonatal faculty and NICU policies and routine practices
Study NCT05966415 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Endocalyx Pro
Description: 4 capsules once daily OR 2 capsules twice daily.
Study NCT05951881 — intervention group
Intervention type: OTHER
Intervention: Emergency Care Unit - medicines
Description: The same group of patients admitted to the emergency room will respond separately to a pharmacist and a pharmacy assistant about their daily medication.~The two medical records will be compared in order to evaluate the work of the pharmacy assistant on the basis of 3 sources :~* the Electronic Medical Record~* the patient's medication history~* the reference pharmacy
Study NCT05966415 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 4 capsules once daily OR 2 capsules twice daily
Study NCT05901402 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: aerobic and resistance exercise
Description: The experimental group performed aerobic resistance exercise during pregnancy every day.
Study NCT06432803 — intervention group
Intervention type: OTHER
Intervention: PET-Scan analysis
Description: Investigate and determine the clinical value of different cortex/striatal metabolic ratio patterns in each antibody-specific subtype of autoimmune encephalitis
Study NCT05516862 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dragons acupuncture
Description: The treatment we are studying is supposed to help the rational and emotional brain effectively communicate, so that the emotional brain can finally realize the trauma experienced is no longer a threat. We call this re-processing. It does not take away the memory but it allows the rational brain to see the memory as just a memory without the emotional brain initiating your fight, flight or freeze system. This allows the mind to take the file off the messy desk and put it away. The treatment was named by the Chinese and is called External and Internal Dragons. According to the Chinese, the External Dragons represent all the bad (traumatic) things that happen to us. The Internal Dragons live inside us, and fight off the External Dragons.~Subject will lay on your stomach and have 7 needles placed in head, upper back, lower back and ankles.
Study NCT05516862 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Dragons acupressure
Description: The treatment we are studying is supposed to help the rational and emotional brain effectively communicate, so that the emotional brain can finally realize the trauma experienced is no longer a threat. We call this re-processing. It does not take away the memory but it allows the rational brain to see the memory as just a memory without the emotional brain initiating your fight, flight or freeze system. This allows the mind to take the file off the messy desk and put it away. The treatment was named by the Chinese and is called External and Internal Dragons. According to the Chinese, the External Dragons represent all the bad (traumatic) things that happen to us. The Internal Dragons live inside us, and fight off the External Dragons.~Subject will lay on your stomach and have 7 small acupressure adhesive bandages placed on head, upper back, lower back and ankles.
Study NCT05516862 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Dragons placebo
Description: The treatment we are studying is supposed to help the rational and emotional brain effectively communicate, so that the emotional brain can finally realize the trauma experienced is no longer a threat. We call this re-processing. It does not take away the memory but it allows the rational brain to see the memory as just a memory without the emotional brain initiating your fight, flight or freeze system. This allows the mind to take the file off the messy desk and put it away. The treatment was named by the Chinese and is called External and Internal Dragons. According to the Chinese, the External Dragons represent all the bad (traumatic) things that happen to us. The Internal Dragons live inside us, and fight off the External Dragons.~Subject will lay on your stomach and the doctor will touch 7 points on head, upper back, lower back and ankles.
Study NCT06632964 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant oncolytic adenovirus injection solution of VT-101
Description: Active ingredient: VT-101 recombinant oncolytic adenovirus Specifications: 2×10\^10 IFU/ml, 0.5ml/ capsule Method of administration: intravesical perfusion
Study NCT06170216 — intervention group
Intervention type: DRUG
Intervention: immunochemotherapies
Description: Observing different immunochemotherapies in small B-cell non-Hodgkin lymphoma (iNHL), which are chosen by investigators, such as RCHOP, BR, RCVP, etc.
Study NCT06328049 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trilaciclib Injection
Description: Patients with lung adenocarcinoma were given Trilaciclib combined with pemetrexed and carboplatin, Q3W; For patients with lung squamous cell carcinoma,Trilaciclib combined with paclitaxel/albumin-bound paclitaxel and carboplatin, Q3W. From cycle 2 onwards, patients chose whether to use trasylol with chemotherapy.
Study NCT04805112 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Provision of multiple self-tests
Description: Participants will be given multiple Oraquick Advance HIV-1/2 test kits to distribute to their sexual partners for partner testing or couple testing. Phone interviews will be conducted with the participants to assess whether they provided a HIV self-test to their partner, if the test was used, how it was used (partner testing or couple testing), if the partner disclosed his results, the partner's reaction to the results, and if the partner went for confirmatory testing
Study NCT04080466 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Low-dose CT Scan
Description: Low dose computed tomography, also known as qCT, is sensitive to the mineral content within bone tissue, and can assess bone mineral density, a strong predictor of bone strength and stiffness, which can influence the health of the cartilage. Participants will undergo a low dose CT scan of both hips.~Participants in the Cam Group will undergo this scan once as part of their standard of care. Participants in the Control Group will undergo this scan once as part of the study.
Study NCT04080466 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Low-dose CT Scan
Description: Low dose computed tomography, also known as qCT, is sensitive to the mineral content within bone tissue, and can assess bone mineral density, a strong predictor of bone strength and stiffness, which can influence the health of the cartilage. Participants will undergo a low dose CT scan of both hips.~Participants in the Cam Group will undergo this scan once as part of their standard of care. Participants in the Control Group will undergo this scan once as part of the study.
Study NCT04080466 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood/Urine Collection
Description: Collection of blood and urine allows the researchers to look for a biomarker in the blood and urine that might help to predict the evolution of disease/hip osteoarthritis. Identifying a marker in the blood and urine that could be used for early detection of individuals with cam deformity that are at-risk of hip degeneration could greatly improve patient care.~Participants in the Cam Group will undergo the blood and urine collection twice; once before surgery and once 2-years post-operative. Participants in the Control Group will undergo a blood and urine collection once as part of the study.